|
US5688825A
(en)
*
|
1996-05-31 |
1997-11-18 |
University Of Connecticut |
Anandamide amidase inhibitors as analgesic agents
|
|
ATE277921T1
(de)
*
|
1998-05-04 |
2004-10-15 |
Univ Connecticut |
Selektiv auf den cb2-rezeptor wirkende cannabinoide
|
|
ATE247097T1
(de)
*
|
1998-05-04 |
2003-08-15 |
Univ Connecticut |
Analgetische und immunomodulierende cannabinoiden
|
|
US7589220B2
(en)
|
1998-06-09 |
2009-09-15 |
University Of Connecticut |
Inhibitors of the anandamide transporter
|
|
US7897598B2
(en)
*
|
1998-06-09 |
2011-03-01 |
Alexandros Makriyannis |
Inhibitors of the anandamide transporter
|
|
WO1999064389A1
(en)
*
|
1998-06-09 |
1999-12-16 |
Alexandros Makriyannis |
Inhibitors of the anandamide transporter as analgesic agents
|
|
US7276613B1
(en)
*
|
1998-11-24 |
2007-10-02 |
University Of Connecticut |
Retro-anandamides, high affinity and stability cannabinoid receptor ligands
|
|
US7161016B1
(en)
|
1998-11-24 |
2007-01-09 |
University Of Connecticut |
Cannabimimetic lipid amides as useful medications
|
|
WO2000066260A1
(en)
|
1999-04-28 |
2000-11-09 |
Toray Industries, Inc. |
Materials for eliminating cannabinoids and columns for the elimination of cannabinoids with the use of the same
|
|
GB9923738D0
(en)
*
|
1999-10-07 |
1999-12-08 |
Nestle Sa |
Nutritional composition
|
|
US7741365B2
(en)
*
|
1999-10-18 |
2010-06-22 |
University Of Connecticut |
Peripheral cannabinoid receptor (CB2) selective ligands
|
|
US6943266B1
(en)
*
|
1999-10-18 |
2005-09-13 |
University Of Connecticut |
Bicyclic cannabinoid agonists for the cannabinoid receptor
|
|
US6900236B1
(en)
*
|
1999-10-18 |
2005-05-31 |
University Of Connecticut |
Cannabimimetic indole derivatives
|
|
MXPA02005103A
(es)
|
1999-10-18 |
2003-09-25 |
Alexipharma Inc |
Ligandos selectivos del receptor de canabinoide (cb2) perifericos.
|
|
US8084467B2
(en)
*
|
1999-10-18 |
2011-12-27 |
University Of Connecticut |
Pyrazole derivatives as cannabinoid receptor antagonists
|
|
US7393842B2
(en)
*
|
2001-08-31 |
2008-07-01 |
University Of Connecticut |
Pyrazole analogs acting on cannabinoid receptors
|
|
US7119108B1
(en)
|
1999-10-18 |
2006-10-10 |
University Of Connecticut |
Pyrazole derivatives as cannabinoid receptor antagonists
|
|
MXPA02005102A
(es)
*
|
1999-10-18 |
2003-09-25 |
Alexipharma Inc |
Retro-anandamidas, ligandos de receptor de canabinoide de alta afinidad y estabilidad.
|
|
ES2181601B2
(es)
*
|
2001-07-27 |
2004-04-01 |
Univ Madrid Complutense |
Derivados de acido araquidonico con afinidad por el transportador de anandamida
|
|
ES2174716B1
(es)
*
|
2000-07-28 |
2004-08-01 |
Universidad Complutense De Madrid |
Nuevos derivados de acido araquidonico con afinidad por el transportador de anandamida.
|
|
AU2001284061A1
(en)
*
|
2000-07-28 |
2002-02-18 |
Universidad Complutense De Madrid |
Novel araquidonic acid derivatives with affinity toward the anandamide transporter
|
|
CA2435409A1
(en)
*
|
2001-01-26 |
2002-08-01 |
University Of Connecticut |
Novel cannabimimetic ligands
|
|
WO2002060447A1
(en)
|
2001-01-29 |
2002-08-08 |
University Of Connecticut |
Receptor selective cannabimimetic aminoalkylindoles
|
|
CA2437353A1
(en)
*
|
2001-02-08 |
2002-08-15 |
Nps Pharmaceuticals, Inc. |
Methods and compounds for treating neurologic or neuropsychiatric disorders and identifying compounds to treat the same
|
|
WO2003005960A2
(en)
*
|
2001-07-13 |
2003-01-23 |
University Of Connecticut |
Novel bicyclic and tricyclic cannabinoids
|
|
WO2003009815A2
(en)
|
2001-07-25 |
2003-02-06 |
Biomarin Pharmaceutical Inc. |
Compositions and methods for modulating blood-brain barrier transport
|
|
WO2003035005A2
(en)
*
|
2001-10-26 |
2003-05-01 |
University Of Connecticut |
Heteroindanes: a new class of potent cannabimimetic ligands
|
|
EP1482917B1
(en)
*
|
2002-02-01 |
2019-05-08 |
GW Pharma Limited |
Compositions comprising cannabidiolic acid for treatment of nausea, vomiting, emesis, motion sickness or like conditions
|
|
US20040063726A1
(en)
*
|
2002-02-08 |
2004-04-01 |
Artman Linda D |
Methods and compounds for treating neurologic or neuropsychiatric disorders and identifying compounds to treat the same
|
|
IL148244A0
(en)
|
2002-02-19 |
2002-09-12 |
Yissum Res Dev Co |
Anti-nausea and anti-vomiting activity of cannabidiol compounds
|
|
AU2003228654A1
(en)
*
|
2002-04-29 |
2003-11-17 |
The General Hospital Corporation |
Compositions and methods for preventing abuse of orally administered medications
|
|
US7049329B2
(en)
|
2002-05-16 |
2006-05-23 |
Sepracor Inc. |
Amines that inhibit a mammalian anandamide transporter, and methods of use thereof
|
|
DE60320784D1
(de)
*
|
2002-06-06 |
2008-06-19 |
Yissum Res Dev Co |
Stände zur modulierung des knochenwachstums
|
|
AU2003265663A1
(en)
|
2002-08-23 |
2004-03-11 |
University Of Connecticut |
Keto cannabinoids with therapeutic indications
|
|
GB0403864D0
(en)
|
2004-02-20 |
2004-03-24 |
Ucl Ventures |
Modulator
|
|
US8847766B2
(en)
|
2005-04-28 |
2014-09-30 |
Proteus Digital Health, Inc. |
Pharma-informatics system
|
|
JP2010503710A
(ja)
|
2006-09-18 |
2010-02-04 |
ラプトール ファーマシューティカル インコーポレイテッド |
受容体関連タンパク質（ｒａｐ）結合体の投与による肝障害の処置
|
|
US7781650B2
(en)
*
|
2007-04-30 |
2010-08-24 |
Monsanto Technology Llc |
Plants and seeds of corn variety CV202909
|
|
CA2702950A1
(en)
*
|
2007-10-16 |
2009-04-23 |
Northeastern University |
Methods and compounds for modulating cannabinoid activity
|
|
EP2398500B1
(en)
|
2009-02-20 |
2019-03-13 |
2-BBB Medicines B.V. |
Glutathione-based drug delivery system
|
|
BRPI1011188B1
(pt)
|
2009-05-06 |
2019-10-15 |
Laboratory Skin Care, Inc. |
Composições de liberação dérmica compreendendo complexos de partículas de agente ativo-fosfato de cálcio e métodos para usar as mesmas
|
|
US20120077778A1
(en)
|
2010-09-29 |
2012-03-29 |
Andrea Bourdelais |
Ladder-Frame Polyether Conjugates
|
|
WO2015188120A1
(en)
*
|
2014-06-06 |
2015-12-10 |
The Scripps Research Institute |
Sulfur(vi) fluoride compounds and methods for the preparation thereof
|
|
CN112121852B
(zh)
*
|
2020-08-27 |
2021-09-24 |
中山大学 |
催化剂组合物及催化剂组合物或催化剂用于催化亲核取代反应的用途
|